Burn Clinical Trial
Official title:
Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes.
Patients will be randomized prospectively to one of two groups. One group will receive 5
mg/kg of 1% lidocaine, and the other will receive .9 normal saline, instilled into their VAC
sponge ½ hour prior to VAC dressing change. All patients will complete a pain assessment tool
prior to receiving the instilled lidocaine/placebo, immediately after the procedure and 1
hour after the procedure. Pain scores will then be compared between the lidocaine and placebo
groups.
Risks: Lidocaine toxicity is a potential risk, but 5 mg/kg of 1 % Lidocaine is below toxicity
thresholds in an adult.
• All Burn service patients (inpatients and outpatients in burn clinic) who are receiving VAC therapy will be screened for study inclusion criteria. Those with allergies to lidocaine will be excluded. Participants will be enrolled until a sample size of 80 wound VAC changes is achieved. Up to 4 VAC dressing changes can be included in this study per participant. Subjects will be randomized prospectively for each dressing change. Utilizing a randomized bracketed approach, patients will be assigned to one of two groups: Lidocaine group or Placebo group. The Pharmacy Research Center (PRC) will assign patient a study Identification (ID) number and record it along with their medical record number on the Master Study ID List. They will then randomize the participants by drawing randomly shuffled green vs white index cards. (40 white card = 0.9 normal saline and 40 green card = 5 mg/kg of 1% Lidocaine). They will draw up the appropriate amount of medication to be used, label it with the patients Medical Record (MR) #, date, and administration instructions and deliver it to the nurse who is doing the VAC dressing change. They will keep the Master Randomization Data Collection Tool in a locked drawer in her office. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT01302457 -
Oral Care Study on Burn Patients
|
N/A | |
Completed |
NCT02729259 -
H2O VR for Burns 2015
|
N/A | |
Completed |
NCT01965340 -
Impact of Therapeutic Drug Monitoring on Anti-Infective Agents Amongst Severely Burned Patients Requiring ICU Admission
|
N/A | |
Withdrawn |
NCT01225107 -
Effect of Cranberry Extract on Infections in Burn Patients
|
N/A | |
Completed |
NCT01983280 -
The Effect of Healing Touch on Sleep Patterns of Pediatric Burn Patients
|
N/A | |
Completed |
NCT00591448 -
Study in the Use of Virtual Reality as an Adjunct to Pain Control in Burn Patients
|
N/A | |
Active, not recruiting |
NCT02083900 -
Use of Banana Leaf Dressing on Donor Site Wounds
|
Phase 2 | |
Completed |
NCT00242970 -
Hypertrophic Scarring After Facial Burn
|
Phase 2 | |
Terminated |
NCT00591162 -
Bone Disease in Severely Burned Children
|
Phase 2/Phase 3 | |
Terminated |
NCT02452255 -
Fenofibrate and Propranolol in Burn Patients
|
Phase 2/Phase 3 | |
Completed |
NCT03183622 -
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-BI-101 Clinical Trial
|
N/A | |
Completed |
NCT02427659 -
VR High Tech Pain Control Burn Wound Care
|
N/A | |
Not yet recruiting |
NCT00253279 -
Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans
|
Phase 1 | |
Completed |
NCT04516148 -
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
|
Phase 4 | |
Withdrawn |
NCT02029261 -
Observational Study of Insulin Resistance and Muscle Wasting After Burn Injury
|
||
Completed |
NCT00993889 -
Virtual Reality Analgesia During Pediatric Physical Therapy
|
N/A | |
Terminated |
NCT01062191 -
Altrazeal Range of Motion Study Comparing With Typical Carboxymethyl
|
N/A | |
Completed |
NCT02394873 -
A Study to Evaluate the Safety of ALLO-ASC-DFU in the Subjects With Deep Second-degree Burn Wound
|
Phase 1 | |
Completed |
NCT00239668 -
Multicenter Benchmarking of Functional and Psychosocial Outcomes of Pediatric Burn Survivors
|
||
Completed |
NCT04781348 -
Efficacy of Platelet Rich Plasma Injection Plus Fat Grafting as Compared to Fat Grafting Alone on Burn Scar by Using Vancouver Scar Scale
|
Phase 4 |